|
ChemGenex Pharmaceuticals Limited - Company Profile Snapshot
| Company Profile: |
ChemGenex Pharmaceuticals Limited |
| Ticker: |
CXSP |
| Exchanges: |
OTC |
| 2009 Sales: |
176,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
AUSTRALIA |
| Employees: |
16 |
Business Description
ChemGenex Pharmaceuticals Limited. The Group's principal activity is operating as an integrated biopharmaceutical development company, focused on discovering and developing oncology drugs. Its product candidates include omacetaxine mepesuccinate (formerly known as Ceflatonin, homoharringtonine or HHT), which is and Quinamed (amonafide dihydrochloride). Operations are carried out in Australia and the United States of America.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
